California Continues Responsible Support for Interchangeability of Biologic Drugs

Yesterday, California’s State Assembly Committee on Appropriations took another decisive step when they unanimously voted in support of the revised SB 598 by recommending it back to the full Assembly after minor modifications.

This is another important step taken by the California State Legislature to ensure patients and physicians who are managing chronic conditions are made fully aware of which biologic drug is ultimately administered by the pharmacist.

When battling a serious disease, patients, physicians and pharmacists should work collaboratively to achieve the best medical outcome. Recognizing the importance of communication between the three parties is particularly relevant when a physician prescribes a biologic medicine, which may be personalized to a patients unique course of treatment.

Public Policy  |  Email This Post  |  Printer Friendly
Tags: , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>